Publication

ladademstat combination with azacitidine is a safe and effective treatment in first line acute myeloid leukemia. final results of the Alice Trial

Salamero, O.
; 
Somervaille, Tim C P
; 
Molero, A.
; 
Acuna-Cruz, E.
; 
Perez-Simon, J. A.
; 
Coll, R.
; 
Arnan, M.
; 
Merchan, B.
; 
Perez, A.
; 
Cano, I.
... show 7 more
Citations
Altmetric:
Abstract
Authors
Salamero, O.
Somervaille, Tim C P
Molero, A.
Acuna-Cruz, E.
Perez-Simon, J. A.
Coll, R.
Arnan, M.
Merchan, B.
Perez, A.
Cano, I.
Rodriguez-Veiga, R.
Arevalo, M.
Gutierrez, S.
Buesa, C.
Faller, D. V.
Bosch, F.
Montesinos, P.
Affiliation
Department of Hematology, University Hospital Vall d'Hebron, Experimental Hematology Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona
Description
Date
2022
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Salamero O, Somervaille TCP, Molero A, Acuna-Cruz E, Perez-Simon JA, Coll R, et al. ladademstat Combination with Azacitidine Is a Safe and Effective Treatment in First Line Acute Myeloid Leukemia. Final Results of the Alice Trial. Blood. 2022 Nov;140:1711-3. PubMed PMID: WOS:000893223201298.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/626114
Embedded videos